Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With DiabetesOriginal Research · 2008 · 100 citations
2. 2Medication Costs, Adherence, And Health Outcomes Among Medicare BeneficiariesCohort Study · 2003 · 324 citations
3. 3Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017Retrospective Study · 2019 · 21 citations
4. 49. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2020</i>Original Research · 2019 · 919 citations